Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer. Burger AVM, Duinkerken CW, van Sluis KE, de Boer JP, et al. Eur Arch Otorhinolaryngol 2024 Sep 6. doi: 10.1007/s00405-024-08880.

Read + Share

Amedeo Smart

Independent Medical Education

Burger AVM, Duinkerken CW, van Sluis KE, de Boer JP, et al. Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer. Eur Arch Otorhinolaryngol 2024 Sep 6. doi: 10.1007/s00405-024-08880.
PMID: 39242413